Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus

BACKGROUND AND OBJECTIVES: Linagliptin is a dipeptidyl peptidase (DPP)-4 inhibitor, used to treat type 2 diabetes mellitus (T2DM). Population pharmacokinetic and pharmacodynamic analyses were performed to characterize the impact of clinically relevant intrinsic/extrinsic factors (covariates) on lina...

Descripción completa

Detalles Bibliográficos
Autores principales: Retlich, Silke, Duval, Vincent, Graefe-Mody, Ulrike, Friedrich, Christian, Patel, Sanjay, Jaehde, Ulrich, Staab, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486092/
https://www.ncbi.nlm.nih.gov/pubmed/25637172
http://dx.doi.org/10.1007/s40262-014-0232-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486092/
https://www.ncbi.nlm.nih.gov/pubmed/25637172
http://dx.doi.org/10.1007/s40262-014-0232-4

Ejemplares similares